Allianz Asset Management Gmb H Alector, Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$10.54 - $24.96 $875,621 - $2.07 Million	-83,076 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $113,483 - $171,807	-5,189 Reduced 5.88%	83,076 $2.03 Million
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $846,917 - $1.84 Million	52,118 Added 144.18%	88,265 $2.13 Million
Q4 2019 Feb 13, 2020	BUY	$14.17 - $20.3 $20,702 - $29,658	1,461 Added 4.21%	36,147 $623,000
Q3 2019 Nov 13, 2019	BUY	$14.42 - $22.2 $500,172 - $770,029	34,686 New	34,686 $504,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.